Business Insights

In this episode on the future of healthcare, our partner Thilo Kaltenbach speaks with Prof. Dr. med. Harald HHW Schmidt about the rise of network pharmacology and its potential to transform pharmaceutical research and development. The conversation explores how moving beyond organ-based definitions of disease could enable a step change in treating root causes rather than symptoms.
What will this mean for pharma business models, clinical pathways, and the health systems of tomorrow?
For more information, visit our website at rolandberger.com.

In this episode, our partners Thilo Kaltenbach and Karsten Neumann explore the rapidly evolving landscape of AI in healthcare. It is pretty clear that AI is transforming our lives and all industries. However, how does it play out in the highly regulated healthcare market? Is it more revolution or evolution? From early diagnosis to personalized medicine, AI-powered hospitals and workforce changes, the topic highlights the tangible impacts of AI on patients, physicians, and organizations. With executives aware of AI's potential but facing readiness gaps, key strategic moves need to be executed to stay ahead in this fast-moving field.
For more...

In this episode, biologist, TV anchor, and staYoung founder Nina Ruge joins our partner Thilo Kaltenbach to explore the increasing focus on life expectancy and health span. Both have risen significantly over the past century, and new medicines and nutritional supplements are now shaping the next phase of the market for healthy aging.
As aging affects everyone, the longevity sector is creating new opportunities for pharma companies, healthcare providers, and investors. With the market expected to double to $60 billion by 2033, early investments in innovation could deliver strong returns.
For more information, visit our website at rolandberger.com.

In this episode, our experts Thilo Kaltenbach and Marina Gilic discuss the growing importance of Environmental, Social, and Governance (ESG) in the MedTech industry. As regulations evolve and customer expectations shift, companies must meet increasing demands for sustainability, patient access, and governance compliance.
Beyond meeting requirements, ESG also presents a significant business opportunity. MedTech companies that embrace ESG can strengthen their positioning as problem solvers, service leaders, and innovators in their field. How can businesses navigate these challenges and develop responsible strategies?
For more information, visit our website at rolandberger.com.